Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Icon Cancer Foundation is an Australian non-profit organization that serves as the clinical research arm of Icon Group, one of the largest private cancer care providers in the region. The foundation is dedicated to improving patient outcomes by facilitating access to international clinical trials across Phase I to Phase IV, covering a broad spectrum of oncology and hematology indications. By leveraging Icon Group's extensive network of cancer centers, the foundation coordinates complex research protocols involving diverse modalities such as immunotherapies, targeted small molecules, and radiopharmaceuticals. The organization collaborates closely with global pharmaceutical companies, academic institutions, and biotech firms to bring innovative therapies to patients in Australia and beyond. Its activities encompass trial coordination, data management, and patient support, ensuring that research is integrated directly into clinical practice.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Icon Cancer Foundation.